Comparisons of
Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study. The gene discussed is ACE; the disease is staphylococcus aureus infection.